Project #339

Project #339 - GARD LTD - Israel

Date: 2007/06/23 / Deadline: 2012/12/31

Contact

Organisation / GARD LTD / Department
Contact person / Fleishman, Mr Guy
Email /
Address / Mifraz Slomo 2
Postcode / 58498 / City / Holon
Country / Israel
Telephone / 972 52 6402520 / Fax
Website

Familiar with the European Framework Programme? YES

PROJECT

Title: BCT: Novel highly efficient Methodology for Breast Cancer Therapy / Acronym: BCT
Project type / Large-scale integrating collaborative project, Small or medium-scale focused research collaborative project, Targeted to SMEs
Status / Planned for submission
Call references / Call 2nd
Priorities’ Main Research Areas / Cancer or HIV treatment.
Workprogramme Topic (according to each priority workprogramme)
Project description
The aim is to develop novel methodologies that make use of advanced technologies to aid in improving the treatment of breast cancer. Improving targeted drug delivery to cancer cells.
First step: The research to better understand the mechanisms underlying breast cancer and to translate this into clinical treatment. The research will lead to better strategies in cancer treatment, prevention and improve patient care.
Second step: Implementation of the research results. The projects will exploit our knowledge to develop new treatment strategies. Project will contribute to reaching the aims of reducing cancer’s mortality and improving quality of life for patients.
Keywords / cancer, siRNA, human erythrocyte, sonoporation,breast cancer therapy, ultrasound
Partners already involved
Project budget (for the running projects) / nc / Budget reserved for SMEs / nc

Research topics

• HEALTH-2007-1.1-4: SME-driven collaborative research projects for developing tools and technologies for high-throughput research
• HEALTH-2007-2.4.1-9: Innovative combination clinical trials for multimodal cancer therapy.

Profile of SME sought

Role / research, dissemination, demonstration
Country /region / Any
Start of partnership / start-up phase
Expertise required / The partner's interests should be:
Breast cancer researches and experts
Expertise in efficient methods for carrier preparation and the nucleotide encapsulation in the erythrocyte vector;
Expertise in intracellular transport and activities of siRNA;
Researches of carrier transport, release and biodegradation pathways in situ and in vivo models;
Researches experienced in ultrasound methods.
Clinical experts to guarantee a clinical proof-of-principle